Previous 10 | Next 10 |
Gainers: Tiziana Life Sciences (NASDAQ: TLSA ) +35% . Appliance Recycling Centers of America (NASDAQ: ARCI ) +24% . Travelzoo (NASDAQ: TZOO ) +18% . Socket Mobile (NASDAQ: SCKT ) +16% . AXT (NASDAQ: AXTI ) +15% . Atossa Genetics (NASDAQ: ATOS ) +12% . Brightcove (NASDAQ: BCOV )...
Consolidated Communications CNSL -26% on Q1 earnings . More news on: Moleculin Biotech, Inc., Huami Corporation, Midatech Pharma Plc, Stocks on the move, , Read more ...
Gainers: Quorum Health (NYSE: QHC ) +38% . Speedway Motorsports (NYSE: TRK ) +33% . Entegra Financial (NASDAQ: ENFC ) +25% . Midatech Pharma (NASDAQ: MTP ) +24% . Appliance Recycling Centers of America (NASDAQ: ARCI ) +23% . Nordic American Offshore (NYSE: NAO ) +23% . Synalloy...
Gainers: Atossa Genetics (NASDAQ: ATOS ) +28% . Immunic (NASDAQ: IMUX ) +22% . Akari Therapeutics (NASDAQ: AKTX ) +19% . Superconductor Technologies (NASDAQ: SCON ) +18% . X4 Pharmaceuticals (NASDAQ: XFOR ) +17% . Hasbro (NASDAQ: HAS ) +16% . Twitter (NYSE: TWTR ) +16% . Trova...
Moleculin Biotech (NASDAQ: MBRX ) has entered into definitive agreements to purchase an aggregate of 9,375,000 units at $1.60 per unit in a registered direct offering, for gross proceeds of ~$15M. More news on: Moleculin Biotech, Inc., Healthcare stocks news, Stocks on the move, ...
Emerge Energy Services (NYSE: EMES ) -64% after entering into a restructuring support agreement with lenders, noteholders and other parties. More news on: Emerge Energy Services LP, Moleculin Biotech, Inc., Regional Health Properties, Inc., Stocks on the move, R...
HOUSTON , April 23, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced that it has entered into definitive ag...
Biotech Brief: Optimistic Outlook Growing for Multi-Billion Dollar Medical Device Industry April 23, 2019 Palm Beach, FL –April 23, 2019 – A recent industry article reported on an optimistic overview concerning the Medical Device Industry. It said: “The medical...
Moleculin Biotech (NASDAQ:MBRX) has got investors on the edge of their seats. On Monday, April 22, the company said it made a “significant discovery” for lung cancer and will be discussing it on a conference call this Wednesday, April 24. On the news, MBRX stock shot up in p...
Gainers: Regional Health Properties (NYSEMKT: RHE ) +183% . Moleculin Biotech (NASDAQ: MBRX ) +51% . The KeyW Holding (NASDAQ: KEYW ) +43% . Key Energy Services (NYSE: KEG ) +32% . Iconix Brand Group (NASDAQ: ICON ) +25% . Lantronix (NASDAQ: LTRX ) +15% . Denbury Resources (NYS...
News, Short Squeeze, Breakout and More Instantly...
Moleculin Biotech Inc. Company Name:
MBRX Stock Symbol:
NASDAQ Market:
Moleculin Biotech Inc. Website:
Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial PR Newswire Based on an encouraging discussion in the End of Phase 1B /2 Meeting with FDA the Company plans to: Proceed with a pivotal, adaptive Phase 3 clinical trial (the "MIRACLE" trial) designed for po...
Moleculin Completes End of Phase 2 Meeting with FDA for Annamycin in AML PR Newswire HOUSTON , July 10, 2024 /PRNewswire/ -- Moleculin Biotech, Inc. , (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfoli...
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...